Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP663825.RA3J5zSH0N5Tl8EWBlX_mbcpqNByzaSzN8YsliQ0tnqPE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP663825.RA3J5zSH0N5Tl8EWBlX_mbcpqNByzaSzN8YsliQ0tnqPE130_assertion type Assertion NP663825.RA3J5zSH0N5Tl8EWBlX_mbcpqNByzaSzN8YsliQ0tnqPE130_head.
- NP663825.RA3J5zSH0N5Tl8EWBlX_mbcpqNByzaSzN8YsliQ0tnqPE130_assertion description "[Therefore, TAP expression restores both antigen presentation and immunogenicity in A375 melanoma cells and concomitantly increases IL-12 and IFN-gamma production in tumor antigen-specific CTLs; TAP should be considered as a part of the immunotherapies for MM.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP663825.RA3J5zSH0N5Tl8EWBlX_mbcpqNByzaSzN8YsliQ0tnqPE130_provenance.
- NP663825.RA3J5zSH0N5Tl8EWBlX_mbcpqNByzaSzN8YsliQ0tnqPE130_assertion evidence source_evidence_literature NP663825.RA3J5zSH0N5Tl8EWBlX_mbcpqNByzaSzN8YsliQ0tnqPE130_provenance.
- NP663825.RA3J5zSH0N5Tl8EWBlX_mbcpqNByzaSzN8YsliQ0tnqPE130_assertion SIO_000772 18385764 NP663825.RA3J5zSH0N5Tl8EWBlX_mbcpqNByzaSzN8YsliQ0tnqPE130_provenance.
- NP663825.RA3J5zSH0N5Tl8EWBlX_mbcpqNByzaSzN8YsliQ0tnqPE130_assertion wasDerivedFrom befree-2016 NP663825.RA3J5zSH0N5Tl8EWBlX_mbcpqNByzaSzN8YsliQ0tnqPE130_provenance.
- NP663825.RA3J5zSH0N5Tl8EWBlX_mbcpqNByzaSzN8YsliQ0tnqPE130_assertion wasGeneratedBy ECO_0000203 NP663825.RA3J5zSH0N5Tl8EWBlX_mbcpqNByzaSzN8YsliQ0tnqPE130_provenance.